It is the only clinically approved GHR antagonist and has been approved by the FDA for the treatment of acromegaly [reviewed in ref
For diabetes management, the target HbA1c is typically below 7% for most adults, though individualized targets may be appropriate based on age, comorbidities, and hypoglycemia risk
Phase 2 clinical trial data published in the New England Journal of Medicine (Jastreboff et al., 2023) demonstrated mean body weight reductions of up to approximately 24% over 48 weeks in adults with obesity a notable finding, though long-term durability data and head-to-head comparisons with other treatments are not yet available
Most Importantly Wegovy previously known as ozempic india can slow digestion , affecting how your body absorbs other medications taken by mouth
Studies with treatment with GLP-1 analogues in type 2 diabetes have found that the initial postprandial insulin is increased after treatment, and this has been misinterpreted as evidence for a GLP-1 mediated insulin stimulation [28]
At 2 mg, mild queasiness may occur
